Relapsing-remitting multiple sclerosis and Immediate post-injection reaction

---

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Immediate Post-Injection Reaction *:

• female: 82.5 %
• male: 17.5 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Immediate Post-Injection Reaction *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 10.81 %
• 30-39: 29.73 %
• 40-49: 31.08 %
• 50-59: 14.86 %
• 60+: 13.51 %

Common co-existing conditions for these people *:

1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 6.02%
2. Vitamin B12 Deficiency: 1 person, 1.20%
3. Injection Site Reaction: 1 person, 1.20%

Common drugs taken by these people *:

1. Copaxone: 69 people, 83.13%
2. Vitamin D: 8 people, 9.64%
3. Glatiramer Acetate: 6 people, 7.23%
4. Vitamins: 4 people, 4.82%
5. Kesimpta: 4 people, 4.82%
6. Polyethylene Glycol 3350: 2 people, 2.41%
7. Amantadine Hydrochloride: 2 people, 2.41%
8. Vitamin D3: 2 people, 2.41%
9. Nortriptyline Hydrochloride: 2 people, 2.41%
10. Magnesium: 2 people, 2.41%

Common symptoms for these people *:

1. Dyspnea (difficult or laboured breathing): 37 people, 44.58%
2. Chest Pain: 26 people, 31.33%
3. Nausea (feeling of having an urge to vomit): 19 people, 22.89%
4. Headache (pain in head): 15 people, 18.07%
5. Feeling Hot: 15 people, 18.07%
6. Chills (felling of cold): 14 people, 16.87%
7. Rashes (redness): 13 people, 15.66%
8. Dizziness: 12 people, 14.46%
9. Pain In Extremity: 12 people, 14.46%
10. Fatigue (feeling of tiredness): 12 people, 14.46%

Do you take medications and have Immediate post-injection reaction?

- Check whether Immediate post-injection reaction is associated with a drug or a condition